Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Financial Flexibility Index
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. financial flexibility index. Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Financial Flexibility Index of 0.30x as of September 2024. Free cash flow of TL36.27 Million (operating CF TL33.37 Million minus capex TL2.91 Million) represents 0% of total liabilities (TL120.48 Million). See Oncosem Onkolojik Sistemler Sanayi ve Ti free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Financial flexibility index of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023. Historical Financial Flexibility Index trend for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 4 annual periods. Check Oncosem Onkolojik Sistemler Sanayi ve Ti earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Financial Flexibility Index by Year (2020–2023)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. financial flexibility index by year from 2020 to 2023. Year-by-year free cash flow to debt coverage for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For the full cash flow conversion analysis, see Oncosem Onkolojik Sistemler Sanayi ve Ti cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (TRY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.06x | TL-6.54 Million | TL-38.10 Million | TL106.61 Million | ▼ -109.8% |
| 2022 | 0.63x | TL78.71 Million | TL52.69 Million | TL125.50 Million | ▼ -38.4% |
| 2021 | 1.02x | TL51.68 Million | TL51.68 Million | TL50.75 Million | ▲ +194.4% |
| 2020 | 0.35x | TL19.41 Million | TL19.41 Million | TL56.11 Million | — |